🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our work on immune-checkpoint inhibitor resistance in mismatch-repair deficient cancers may offer clues to new immunotherapy strategies in colorectal cancer cancerimmunolres.aacrjournals.org/content/early/…

New research in Nature Communications: Resistance to immune checkpoint blocker drug linked to metabolic imbalance ms.spr.ly/6015TuH5P #KidneyCancer #Melanoma Toni Choueiri, MD Marios Giannakis

Colorectal cancer awareness month at the Dana-Farber Cancer Institute Dana-Farber's Young-Onset Colorectal Cancer Center

Red meat and cancer 🥩 New research led by Dana-Farber's Marios Giannakis, MD, PhD, finds high red meat consumption may promote DNA damage-associated mutations in patients with #colorectalcancer, published in Cancer Discovery: ms.spr.ly/6015nHLrx cc Dana-Farber's Young-Onset Colorectal Cancer Center

We are excited to share our study on spatially organized multicellular immune hubs in human colorectal cancer cell.com/cell/fulltext/… Cell. Joint effort with @karin_pelka, Jonathan Chen, Ana Anderson lab, Orit Rozenblatt-Rosen, Aviv Regev, Nir Hacohen, many others!

Excited to share our latest research showing an oncogenic role and therapeutic options for one of the most frequent Colorectal Cancer mutations Marios Giannakis Dana-Farber Broad Institute nature.com/articles/s4146…

New #ColorectalCancer research from #AACRcrc22 shows an oncogenic role and therapeutic options for one of the most frequent colorectal cancer mutations: RNF43 G659fs. Research presented by Dana-Farber's Marios Giannakis, MD, PhD (Marios Giannakis)

Read more in the The ASCO Post on research into the effectiveness of a molecular tumor board in precision oncology for patients with gastrointestinal cancer treated at the Dana-Farber Brigham Cancer Center. CC: Dana-Farber's Young-Onset Colorectal Cancer Center Marios Giannakis Read more ➡️ bit.ly/3CYAg0r

Young-onset #ColorectalCancer: A common cancer at an uncommon age. Publishing online in Science Magazine, Dana-Farber's Kimmie Ng, MD, MPH and Marios Giannakis chart a course to better understand, prevent, and treat the disease. Read: bit.ly/3mTGtFP CC: Dana-Farber's Young-Onset Colorectal Cancer Center

Must-read perspective by Marios Giannakis & Kimmie Ng, MD, MPH on the ongoing epidemic of early-onset colorectal cancer diagnoses. Reasons likely complex/multi factorial, in need of deep investigation in order to revert this concerning phenomenon. science.org/doi/10.1126/sc…

I’m on the Science Magazine weekly podcast to talk about the Perspective piece that Marios Giannakis and I wrote on #YoungOnsetColorectalCancer. Tune in to the conversation by clicking below! Dana-Farber's Young-Onset Colorectal Cancer Center Dana-Farber Dana-Farber News

Dr. Kimmie Ng says researchers are evaluating a range of factors that could be fueling a rise in colon cancer, everything from a lack of vitamin D, to the complicated role of the microbiome. CC: Kimmie Ng, MD, MPH Dana-Farber's Young-Onset Colorectal Cancer Center NPR npr.org/sections/healt…

1/4 New Perspectives piece from Marios Giannakis and Kimmie Ng, MD, MPH of team OPTIMISTICC in Science Magazine discusses the rising global incidence of early-onset colorectal cancer (EOCRC) science.org/doi/10.1126/sc…